Reports Q1 revenue $143.6M, consensus $145.83M. Total IQVIA prescriptions were 176,503 for first quarter 2024, an increase of 31% compared to the prior year period.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SUPN:
- M8 Pharmaceuticals signs licensing agreement with Supernus
- SUPN Upcoming Earnings Report: What to Expect?
- Supernus partners with Busy Philipps to shine spotlight on ADHD in women
- Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
- Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024